PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29155323-7	2018	Pretreatment with P2X7R antagonist Brilliant Blue G (BBG) could also block the mechanical allodynia, inhibited the phosphorylation of c-Raf, MEK, ERK1/2, and decrease the expression of TNF-alpha.	coomassie Brilliant Blue	35-51	tumor necrosis factor	Rattus norvegicus	185-194	
32516946-7	2020	Increased IL-2, IL-6, TNFalpha, IL-1beta, IL-18 and overexpression of NLRP3 inflammasome were induced by angiotensin II and suppressed by BBG.	coomassie Brilliant Blue	138-141	tumor necrosis factor	Rattus norvegicus	22-30	
29155323-7	2018	Pretreatment with P2X7R antagonist Brilliant Blue G (BBG) could also block the mechanical allodynia, inhibited the phosphorylation of c-Raf, MEK, ERK1/2, and decrease the expression of TNF-alpha.	coomassie Brilliant Blue	53-56	tumor necrosis factor	Rattus norvegicus	185-194	
33548287-8	2021	BBG administration, but not OLT1177, reduced the expression of Myd88, NF-kappaB, IL-6, and TNF-alpha in addition to lowering P2X7R and oxidative stress levels.	coomassie Brilliant Blue	0-3	tumor necrosis factor	Rattus norvegicus	91-100	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	25-41	tumor necrosis factor	Rattus norvegicus	115-142	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	25-41	tumor necrosis factor	Rattus norvegicus	144-153	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	43-46	tumor necrosis factor	Rattus norvegicus	115-142	
32733956-9	2020	Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation.	coomassie Brilliant Blue	43-46	tumor necrosis factor	Rattus norvegicus	144-153	
23688519-4	2013	Administration of brilliant blue G (BBG), a selective P2X7 antagonist, decreased the elevation of systolic blood pressure, heart rate, serum cardiac enzyme, IL-6 and TNF-alpha, and inhibited the up-regulated expression of P2X7 mRNA and protein in DRG and SG after myocardial ischemic injury.	coomassie Brilliant Blue	18-34	tumor necrosis factor	Rattus norvegicus	166-175	
23688519-4	2013	Administration of brilliant blue G (BBG), a selective P2X7 antagonist, decreased the elevation of systolic blood pressure, heart rate, serum cardiac enzyme, IL-6 and TNF-alpha, and inhibited the up-regulated expression of P2X7 mRNA and protein in DRG and SG after myocardial ischemic injury.	coomassie Brilliant Blue	36-39	tumor necrosis factor	Rattus norvegicus	166-175	
15965498-5	2005	LPS-induced increase in plasma TNF-alpha concentration was also markedly attenuated by BBG (100 mg kg(-1)), but not by PPADS (25 mg kg(-1)).	coomassie Brilliant Blue	87-90	tumor necrosis factor	Rattus norvegicus	31-40	
25933224-6	2015	BBG also ameliorated liver fibrosis and down-regulated hepatic interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), PDGF, IL-1beta, transforming growth factor-beta (TGF-beta), p-extracellular-signal-regulated kinases (ERK), and alpha-smooth muscle actin (alpha-SMA) expressions in CBDL rats.	coomassie Brilliant Blue	0-3	tumor necrosis factor	Rattus norvegicus	85-112	
25933224-6	2015	BBG also ameliorated liver fibrosis and down-regulated hepatic interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), PDGF, IL-1beta, transforming growth factor-beta (TGF-beta), p-extracellular-signal-regulated kinases (ERK), and alpha-smooth muscle actin (alpha-SMA) expressions in CBDL rats.	coomassie Brilliant Blue	0-3	tumor necrosis factor	Rattus norvegicus	114-123